Company
United StatesPublic company, NASDAQ: VSTMVerastem, Inc. (NASDAQ: VSTM), Needham, MA – FDA Inspections
Inspection records and compliance data for Verastem, Inc. in Needham, Massachusetts. 2 FDA inspections on record, 1 Form 483, last inspected February 05, 2025. Publicly traded as NASDAQ: VSTM.
Company Profile
This profile covers Verastem, Inc. based in Needham, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected May 10, 2018. Last inspected February 5, 2025.
Most cited issue areas
- General responsibilities of sponsors1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 5, 2025 | VAI | Human Drugs · Bioresearch Monitoring: Human Drugs | 1260096 |
| May 10, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1053659 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Verastem, Inc.
Stock ticker
VSTM
Exchange
NASDAQ
Share price
$8.44
Market cap
$1.1B
Price as of
November 13, 2026
FEI Number
3011454257
Address
117 Kendrick St Ste 500, Needham, Massachusetts 02494, United States
Country
United States
ID: d477d311-6bcc-4a68-ba12-e2255081e340